Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer

APMIS

Volumn 118, Issue 10, 2010, Pages 782-790

  Cho, Yu Jin ^a   Yoon, Jiyeon ^a   Ko, Young San ^a   Kim, Sue Youn ^a   Cho, Sung Jin ^a   Kim, Woo Ho ^a   Park, Jong Wan ^a   Youn, Hong Duk ^a   Kim, Ji Hun ^b   Lee, Byung Lan ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

catenin; gastric carcinoma; GSK 3 ; immunohistochemistry; tissue microarray

Indexed keywords

BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN BCL 2; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LITHIUM CHLORIDE;

ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; STOMACH TUMOR; TISSUE MICROARRAY; TUMOR CELL LINE; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; LITHIUM CHLORIDE; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 77956917845     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02659.x     Document Type: Article

References (30)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006 12 : 354 62.
2. Sun W, Haller DG. Recent advances in the treatment of gastric cancer. Drugs 2001 61 : 1545 51.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66.
4. Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 2007 64 : 1930 44.
5. Woodgett JR, Cohen P. Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta 1984 788 : 339 47.
6. Doble BW, Woodgett Jr. GSK-3β: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003 116 : 1175 86.
7. Ghosh JC, Altieri DC. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3 in colorectal cancer cells. Clin Cancer Res 2005 11 : 4580 8.
8. Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET, Yu Q. Pharmacologic modulation of glycogen synthase kinase-3 promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res 2005 65 : 9012 20.
9. Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, Billadeau DD, et al. Deregulated GSK3 activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 2005 334 : 1365 73.
10. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, et al. Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 2007 98 : 1388 93.
11. Cao Q, Lu X, Feng YJ. Glycogen synthase kinase-3 positively regulates the proliferation of human ovarian cancer cells. Cell Res 2006 16 : 671 7.
12. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Inactivation of glycogen synthase kinase-3, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 2007 6 : 1151 8.
13. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, et al. Kinase-inactive glycogen synthase kinase 3 promotes Wnt signaling and mammary tumorigenesis. Cancer Res 2005 65 : 5792 801.
14. Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, et al. Regulation of FOXO3aβ-cateninGSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 2007 282 : 21542 50.
15. Wang Q, Zhou Y, Wang X, Evers BM. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells. Cell Death Differ 2008 15 : 908 19.
16. Liao X, Zhang L, Thrasher JB, Du J, Li B. Glycogen synthase kinase-3 suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2003 2 : 1215 22.
17. Soto-Cerrato V, Vinals F, Lambert JR, Kelly JA, Perez-Tomas R. Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3 activity in human breast cancer cells. Mol Cancer Ther 2007 6 : 362 9.
18. Ma C, Wang J, Gao Y, Gao TW, Chen G, Bower KA, et al. The role of glycogen synthase kinase 3 in the transformation of epidermal cells. Cancer Res 2007 67 : 7756 64.
19. Lee JH, Park CH, Jung KC, Rhee HS, Yang CH. Negative regulation of β-cateninTcf signaling by naringenin in AGS gastric cancer cell. Biochem Biophys Res Commun 2005 335 : 771 6.
20. Manoukian AS, Woodgett Jr. Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 2002 84 : 203 29.
21. Al-Aynati MM, Radulovich N, Riddell RH, Tsao MS. Epithelial-cadherin and β-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 2004 10 : 1235 40.
22. Lee BL, Kim WH, Jung J, Cho SJ, Park JW, Kim J, et al. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 2008 29 : 44 51.
23. Lee HS, Lee BL, Kim SH, Woo DK, Kim HS, Kim WH. Microsatellite instability in synchronous gastric carcinomas. Int J Cancer 2001 91 : 619 24.
24. Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003 200 : 39 46.
25. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997 16 : 3797 804.
26. Polakis P. Wnt signaling and cancer. Genes Dev 2000 14 : 1837 51.
27. Kikuchi A. Regulation of β-catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 2000 268 : 243 8.
28. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997 275 : 1787 90.
29. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001 95 : 108 13.
30. Jiang H, Xia J, Kang J, Ding Y, Wu W. Short hairpin RNA targeting β-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells. Scand J Gastroenterol 2009 44 : 1452 62.